1,840
Views
2
CrossRef citations to date
0
Altmetric
Clinical Study

Risk factors and outcomes of cardiovascular disease readmission within the first year after dialysis in peritoneal dialysis patients

, , , , , & show all
Pages 159-167 | Received 29 Jul 2020, Accepted 12 Dec 2020, Published online: 13 Jan 2021

References

  • Ottesen TD, McLynn RP, Zogg CK, Shultz BN, et al. Dialysis is an independent risk factor for perioperative adverse events, readmission, reoperation, and mortality for patients undergoing elective spine surgery. Spine J. 2018;18:2033–2042.
  • Lin Y, Yang C, Chu H, et al., China Kidney Disease Network Working Group. Association between the Charlson Comorbidity Index and the risk of 30-day unplanned readmission in patients receiving maintenance dialysis. BMC Nephrol. 2019;20:363.
  • Flythe JE, Katsanos SL, Hu Y, et al. Predictors of 30-day hospital readmission among maintenance hemodialysis patients: a hospital’s perspective. CJASN. 2016;11:1005–1014.
  • Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2019 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2020;75:A6–A7.
  • Saran R, Robinson B, Abbott KC, et al. US Renal Data System 2018 annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2019;73:A7–A8.
  • Perl J, McArthur E, Bell C, Garg AX, et al. Dialysis modality and readmission following hospital discharge: a population-based cohort study. Am J Kidney Dis. 2017;70:11–20.
  • Li Z, Abreu Z, Penner T, et al. Analysis of hospitalization after peritoneal dialysis catheter implantation. Perit Dial Int. 2016;36:540–546.
  • Sahlie A, Jaar BG, Paez LG, et al. Burden and correlates of hospital readmissions among U.S. peritoneal dialysis patients. Perit Dial Int. 2019;39:261–267.
  • Chan L, Poojary P, Saha A, et al. Reasons for admission and predictors of national 30-day readmission rates in patients with end-stage renal disease on peritoneal dialysis. Clin Kidney J. 2017;10:552–559.
  • Plantinga LC, King LM, Masud T, et al. Burden and correlates of readmissions related to pulmonary edema in US hemodialysis patients: a cohort study. Nephrol Dial Transplant. 2018;33:1215–1223.
  • Krediet RT, Balafa O. Cardiovascular risk in the peritoneal dialysis patient. Nat Rev Nephrol. 2010;6:451–460.
  • US Renal Data System. Annual data report: epidemiology of kidney disease in the United States. Am J Kidney Dis. 2016;69:A4.
  • Molnar AO, Moist L, Klarenbach S, et al. Hospitalizations in dialysis patients in Canada: a national cohort study. Can J Kidney Health Dis. 2018;5:2054358118780372.
  • Laurin LP, Harrak H, Elftouh N, et al. Outcomes of infection-related hospitalization according to dialysis modality. Clin J Am Soc Nephrol. 2015;10:817–824.
  • Wadhera RK, Joynt Maddox KE, Wasfy JH, et al. Association of the hospital readmissions reduction program with mortality among medicare beneficiaries hospitalized for heart failure, acute myocardial infarction, and pneumonia. JAMA. 2018;320:2542–2552.
  • Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305.
  • Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10:1606–1615.
  • Kim HJ, Lee J, Park M, et al. Lower education level is a risk factor for peritonitis and technique failure but not a risk for overall mortality in peritoneal dialysis under comprehensive training system. PLoS One. 2017;12:e0169063.
  • Lin E, Bhattacharya J, Chertow GM. Prior hospitalization burden and the relatedness of 30-day readmissions in patients receiving hemodialysis. J Am Soc Nephrol. 2019;30:323–335.
  • Xia X, Zhao C, Luo Q, et al. Nomogram for predicting cardiovascular mortality in incident peritoneal dialysis patients: an observational study. Sci Rep. 2017;7:13889.
  • Yang X, Yi C, Liu X, et al. Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: a 5-year clinical cohort study. Diabetes Res Clin Pract. 2013;100:354–361.
  • Wetmore JB, Molony JT, Liu J, et al. Readmissions following a hospitalization for cardiovascular events in dialysis patients: a retrospective cohort study. J Am Heart Assoc. 2018;7:e007231.
  • Ross KH, Jaar BG, Lea JP, et al. Long-term outcomes among Medicare patients readmitted in the first year of hemodialysis: a retrospective cohort study. BMC Nephrol. 2019;20:285.
  • Wang H, Zhao T, Wei X, et al. The prevalence of 30-day readmission after acute myocardial infarction: a systematic review and meta-analysis. Clin Cardiol. 2019;42:889–898.
  • Kuo FC, Lin PC, Lu YD, et al. Chronic kidney disease is an independent risk factor for transfusion, cardiovascular complication, and thirty-day readmission in minimally invasive total knee arthroplasty. J Arthroplasty. 2017;32:1630–1634.
  • Altibi AM, Prousi G, Agarwal M, et al. Readmission-free period and in-hospital mortality at the time of first readmission in acute heart failure patients-NRD-based analysis of 40,000 heart failure readmissions. Heart Fail Rev. 2020.
  • Prichard S. Cardiovascular risk in peritoneal dialysis. Contrib Nephrol. 2003:82–90.
  • Townsend RR, Wimmer NJ, Chirinos JA, et al. Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens. 2010;23:282–289.
  • Steiner S, Schaller G, Puttinger H, et al. History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients. Am J Kidney Dis. 2005;46:520–528.
  • Steven S, Frenis K, Oelze M, et al. Vascular inflammation and oxidative stress: major triggers for cardiovascular disease. Oxid Med Cell Longev. 2019; 2019:7092151.
  • Dai L, Golembiewska E, Lindholm B, et al. End-stage renal disease, inflammation and cardiovascular outcomes. Contrib Nephrol. 2017;191:32–43.
  • Ikee R, Hamasaki Y, Oka M, et al. High-density lipoprotein cholesterol and left ventricular mass index in peritoneal dialysis. Perit Dial Int. 2008;28:611–616.
  • Favari E, Thomas MJ, Sorci-Thomas MG. High-density lipoprotein functionality as a new pharmacological target on cardiovascular disease: unifying mechanism that explains high-density lipoprotein protection toward the progression of atherosclerosis. J Cardiovasc Pharmacol. 2018;71:325–331.
  • Cheng LT, Tang LJ, Chen HM, et al. Relationship between serum albumin and pulse wave velocity in patients on continuous ambulatory peritoneal dialysis. VHRM. 2008;4:871–876.
  • Su X, Zhang K, Guo F, et al. Ischemia-modified albumin, a predictive marker of major adverse cardiovascular events in continuous ambulatory peritoneal dialysis patients. Clin Biochem. 2013;46:1410–1413.
  • Sikorska D, Olewicz-Gawlik A, Baum E, et al. The importance of hypoalbuminemia in peritoneal dialysis patients: impact of gender. Adv Clin Exp Med. 2019;28:729–735.
  • Yu Z, Tan BK, Dainty S, et al. Hypoalbuminaemia, systemic albumin leak and endothelial dysfunction in peritoneal dialysis patients. Nephrol Dial Transplant. 2012;27:4437–4445.
  • Aguilera A, Sanchez-Tomero JA, Bajo MA, et al. Malnutrition-inflammation syndrome is associated with endothelial dysfunction in peritoneal dialysis patients. Adv Perit Dial. 2003;19:240–245.
  • Wang AY. Consequences of chronic inflammation in peritoneal dialysis. Semin Nephrol. 2011;31:159–171.
  • Sakaci T, Ahbap E, Koc Y, et al. Clinical outcomes and mortality in elderly peritoneal dialysis patients. Clinics (Sao Paulo). 2015;70:363–368.
  • Provenzano M, Coppolino G, Faga T, et al. Epidemiology of cardiovascular risk in chronic kidney disease patients: the real silent killer. Rev Cardiovasc Med. 2019; 20:209–220.
  • Chan L, Chauhan K, Poojary P, et al. National estimates of 30-day unplanned readmissions of patients on maintenance hemodialysis. CJASN. 2017;12:1652–1662.